Skip to main content
Vireo Growth Inc. logo

Vireo Growth Inc. — Investor Relations & Filings

Ticker · VREO ISIN · CA38238W1032 CSE Manufacturing
Open in API
Filings indexed 543 across all filing types
Latest filing 2024-04-01 Regulatory Filings
Country CA Canada
Listing CSE VREO

About Vireo Growth Inc.

https://vireogrowth.com/

Vireo Growth Inc. is a science-focused cannabis company that cultivates, processes, and distributes medical and adult-use cannabis products. The company emphasizes environmentally friendly cultivation practices, often utilizing greenhouses, and manufactures pharmaceutical-grade cannabis extracts. Vireo Growth operates wholesale and retail business lines, selling its portfolio of branded products through company-owned dispensaries and distribution networks. The company's mission is to provide safe access, quality products, and value to its customers, coupled with a commitment to community support and restorative justice programs.

Recent filings

Filing Released Lang Actions
Annual MD&A - English.pdf
Regulatory Filings
2024-04-01 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a certification pursuant to SEC rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, specifically Section 302 of the Sarbanes-Oxley Act of 2002. It is signed by the Interim CFO and certifies the accuracy and completeness of the Quarterly Report on Form 10-Q. The text does not contain actual financial data or the report itself but is an officer certification related to the 10-Q filing. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS) rather than the report they reference.
2023-11-15 English
News release - English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is a detailed financial report announcing the third quarter 2023 results of Goodness Growth Holdings. It includes comprehensive financial data such as revenue, gross profit, operating income, EBITDA, and detailed management commentary on operational performance and market conditions. The presence of quarterly financial figures, management discussion, and performance metrics indicates this is a quarterly financial report. The document length is substantial (15,000 characters), and it contains actual financial statements and analysis, not just an announcement or summary. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q3 2023
2023-11-15 English
Other material contracts - English.pdf
Legal Proceedings Report Classification · 95% confidence The document is a Confidential Separation Agreement, Waiver and Release between a company and its Chief Financial Officer employee. It details terms of employment separation, compensation, release of claims, and other legal provisions. There is no indication of financial data, regulatory filings, earnings, or corporate governance announcements. It is a legal agreement related to employment termination and severance, not a financial report or regulatory filing. Therefore, it fits best under Legal Proceedings Report (LTR) as it pertains to legal matters and agreements involving the company.
2023-11-15 English
Other material contracts - English.pdf
Regulatory Filings Classification · 95% confidence The document is titled 'First Amendment to Consulting Agreement' and details amendments to a consulting contract between a company and a consultant, including compensation terms and definitions related to adjusted net income calculations. It is a contractual amendment and does not contain financial statements, earnings data, regulatory disclosures, or any form of report publication. It is not an announcement of a report, nor a regulatory filing or certification. The content is purely contractual and related to management agreements rather than financial reporting or corporate governance disclosures. Therefore, it does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. The best fitting category is Regulatory Filings (RNS) as a fallback for miscellaneous filings that do not fit other categories, since this is a formal amendment to a consulting agreement filed with the company but not a financial or governance report.
2023-11-15 English
Other material contracts - English.pdf
M&A Activity Classification · 95% confidence The document is an Option Agreement between Vireo Health, Inc. and HA-MD LLC and its members regarding the option to purchase membership interest units in the company. It details terms of the option, purchase price, option period, due diligence, closing, representations and warranties, and other contractual provisions. There is no indication that this is a financial report, regulatory filing, earnings release, or any other typical corporate filing category. It is a legal contract related to a potential acquisition or purchase option of company units, which aligns with M&A activity. However, it is not a merger or acquisition filing itself but rather an agreement related to a potential future transaction. Given the specificity of the categories, the closest fit is M&A Activity (TAR), which covers announcements and documents related to merger proposals or takeover bids, including option agreements related to acquisitions. The document is substantive and not a mere announcement or notice, so it is not RPA or RNS. Therefore, the best classification is TAR with high confidence.
2023-11-15 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.